Clinical Analysis Department, Hospital Universitario Santa María del Rosell (HUSMR), Cartagena, Spain.
Mol Carcinog. 2012 Jun;51(6):508-13. doi: 10.1002/mc.20814. Epub 2011 Jun 16.
The interrelationship between genetic susceptibility and carcinogenic exposure is important in the development of haematopoietic malignancies. Both factors need to be considered to enable assessment of disease risk associated with a given individual under certain environmental conditions. GSTT1 and GSTM1 are two genes whose proteins are involved in the detoxification of potential carcinogens. We have studied the prevalence of GSTT1 and GSTM1 null polymorphisms using a novel PCR multiplex protocol in a group of 158 patients with B-cell lymphoma (BCL, 138 with non-Hodgkin lymphoma and 20 with Hodgkin lymphoma) and 214 healthy controls. A questionnaire regarding occupational exposure and lifestyle factors was also completed by both groups. GSTM1 null genotype showed no significant differences between patients and controls (46.9% and 55.6%, respectively). In contrast, GSTT1 null genotype was observed in 25.3% of patients and 15.4% of controls (P=0.013; OR=1.85; CI (95%):1.11-3.09), suggesting a role for the GSTT1 null genotype in the development of BCL. This effect was even more evident in females (27.5% vs. 14%: P=0.014). No significant association was observed between GST genotypes and disease risk in relation to smoking or occupational exposure.
遗传易感性和致癌暴露之间的相互关系在血液系统恶性肿瘤的发生中非常重要。这两个因素都需要考虑,以便在特定的环境条件下评估与特定个体相关的疾病风险。GSTT1 和 GSTM1 是两个基因,其蛋白质参与潜在致癌物质的解毒。我们使用一种新的 PCR 多重方案研究了 158 例 B 细胞淋巴瘤(BCL,138 例非霍奇金淋巴瘤和 20 例霍奇金淋巴瘤)和 214 例健康对照者中 GSTT1 和 GSTM1 缺失多态性的流行情况。两组患者和对照组都填写了一份关于职业暴露和生活方式因素的问卷。GSTM1 缺失基因型在患者和对照组之间没有显著差异(分别为 46.9%和 55.6%)。相比之下,GSTT1 缺失基因型在患者中为 25.3%,在对照组中为 15.4%(P=0.013;OR=1.85;95%CI:1.11-3.09),提示 GSTT1 缺失基因型在 BCL 的发生中起作用。这种影响在女性中更为明显(27.5%比 14%:P=0.014)。在与吸烟或职业暴露相关的疾病风险方面,GST 基因型与疾病风险之间没有显著关联。